S100A8 and myeloid leukemia: Importantly, transgenic mice overexpressing phosphorylation-competent CagA developed gastrointestinal adenocarcinoma, myeloid leukemia and B cell lymphoma, while phosphorylation-resistant CagA could not confer the same pathological changes [10].